Aethlon Medical Financials - Benzinga

Aethlon Medical Inc

AEMDNASDAQ

Trade with Public

Trade with Public

$2.49

0.3214.75%

At close: Aug 28, 5:00 PM EST

$2.40

-0.0899-3.61%

After Hours: Aug 28, 7:59 PM EST

Overview News Earnings Forecast Events Price TargetsFinancialsSentiment Ownership Compare Stock Report

Aethlon Medical Financials

Aethlon Medical (AEMD) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
Aethlon Medical Q1 EPS $(4.02) Misses $(0.79) Estimate; Cash & Equivalents $4.9M

Aethlon Medical (NASDAQ:AEMD) reported quarterly losses of $(4.02) per share which missed the analyst consensus estimate of $(0.79) by 415.38 percent. This is a 90.52 percent increase over losses of $(42.42) per share

Benzinga Newsdesk

PRO
Aethlon Medical Q4 EPS $0.40 Beats $(2.02) Estimate

Aethlon Medical (NASDAQ:AEMD) reported quarterly earnings of $0.40 per share which beat the analyst consensus estimate of $(2.02) by 119.9 percent. This is a 110.81 percent increase over losses of $(3.70) per share from

Benzinga Newsdesk

Earnings Scheduled For June 10, 2026

Benzinga Insights

PRO
Aethlon Medical Q3 EPS $(2.45) Beats $(2.57) Estimate

Aethlon Medical (NASDAQ:AEMD) reported quarterly losses of $(2.45) per share which beat the analyst consensus estimate of $(2.57) by 4.67 percent. This is a 135.58 percent decrease over losses of $(1.04) per share from

Benzinga Newsdesk

Earnings Scheduled For February 12, 2026

Benzinga Insights

PRO
Aethlon Medical Q2 EPS $(3.74) Misses $(3.66) Estimate

Aethlon Medical (NASDAQ:AEMD) reported quarterly losses of $(3.74) per share which missed the analyst consensus estimate of $(3.66) by 2.1 percent. This is a 133.75 percent decrease over losses of $(1.60) per share from

Benzinga Newsdesk